(Q68419065)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2140996%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

title

A comparison of nafarelin acetate and danazol in the treatment of endometriosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2140996%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference

S H Kennedy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2140996%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

I A Williams

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2140996%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

J Brodribb

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2140996%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

D H Barlow

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2140996%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

R W Shaw

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2140996%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

language of work or name

English

0 references

publication date

1 June 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2140996%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

published in

Fertility and Sterility

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2140996%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2140996%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2140996%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

page(s)

998-1003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2140996%20AND%20SRC:MED&resulttype=core&format=json

Danazol inhibits steroidogenesis by the human ovary in vivo.

24 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953574-2

Free testosterone levels during danazol therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953574-2

Endocrine effects of danazol in the treatment of endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953574-2

Ultrastructural changes in endometriotic tissue during danazol treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953574-2

Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953574-2

Treatment of endometriosis with danazol: report of a 6-year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953574-2

A comparison of danazol and conservative surgery for the treatment of infertility due to mild or moderate endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953574-2

Collaborative study of pregnancy rates following danazol therapy of stage I endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953574-2

The effectivenss of danazol on subsequent fertility in minimal endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953574-2

Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953574-2

Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953574-2

Revised American Fertility Society classification of endometriosis: 1985

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953574-2

The second-look laparoscopy for evaluation of the result of medical treatment of endometriosis should not be performed during ovarian suppression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953574-2

Profound alterations of the lipoprotein metabolism during danazol treatment in premenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953574-2

Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953574-2

The inhibitory effects of danazol, danazol metabolites, gestrinone, and testosterone on the growth of human endometrial cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953574-2

7 January 2021

Antigonadotropin (danazol) in the treatment of endometriosis. Evaluation of posttreatment fertility and three-year follow-up data

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953574-2

7 January 2021

Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953574-2

7 January 2021

Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953574-2

7 January 2021

Visual assessment of peritoneal implants for staging endometriosis: do number and cumulative size of lesions reflect the severity of a systemic disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953574-2

7 January 2021

10.1016/S0015-0282(16)53574-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2140996%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference